Clinical Trial: Ginger-PD: Ginger as a Modifier of Ghrelin Levels and Gut Function in Parkinson's Disease

U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07882108) titled 'Ginger-PD: Ginger as a Modifier of Ghrelin Levels and Gut Function in Parkinson's Disease' on Oct. 12.

Brief Summary: This study will test whether taking ginger supplements can increase ghrelin, a hunger hormone that is decreased in the blood of people with Parkinson's disease (PD) and REM Sleep Behaviour disorder (RBD). Three groups of participants are taking part:

1. People with Parkinson's disease (PD);

2. People with REM Sleep Behaviour Disorder (RBD);

3. Healthy people of similar age and sex.

We aim to include 24 participants per group. Each participant will take ginger capsules for 12 weeks at one of two dose levels (0.24g...